Notable Labs - NTBL Operating profit EBITDA
EBITDA reflects the cash flow dynamics of Notable Labs, Ltd. (NTBL), where the value represents the current metric. Risks for Notable Labs, Ltd. (NTBL) are tied to validating the accuracy of IT forecasts and partner acquisition costs. Revenue is based on predictive live-cell tests for chemistry selection. Robotic platforms are operating stably and are currently undergoing a technical capacity upgrade.
Summary analytical data breakdowns for Notable Labs (NTBL)
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
- earnings and market ratios statistics:
NTBL - Company Net Income|Expected Profit Notable Labs, Ltd.|NTBL - P/E Multiple|Projected Price to Earnings Ratio notablelabs.com|NTBL - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Notable Labs|NTBL - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Notable Labs|NTBL - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth notablelabs.com|NTBL - Earnings growth in current year|Net earnings per share growth forecast for next year Notable Labs, Ltd.
Fundamental company valuation:Notable Labs Corp NTBL
AI-driven automation of oncology therapy selection is transforming Notable Labs, Ltd. (NTBL) operating expenses into actual cash flow. This metric captures the daily net cash from operating activities, allowing for an assessment of business scale and the risk of overpaying for the asset via cash EBITDA dynamics, which reflect the actual monetization efficiency of high-tech live-cell screening.
Who Notable Labs, Ltd. competes with
ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Profit before payment of interest, taxes and amortization Personalis, Inc. (PSNL)|erasca.com - Operating profit before amortization|Profit before payment of interest, taxes and amortization Delcath Systems DCTH|Y-mAbs Therapeutics Inc (YMAB) - Profit before interest, taxes and amortization|AURA: Operating profit before deduction of amortization|Candel Therapeutics - Company profit before taxes, interest and amortization|ARAY: Operating profit EBITDA|SELLAS Life Sciences Group (SLS) - Operating profit EBITDA|ACTU (Actuate Therapeutics) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization CTOR|Profit before payment of interest, taxes and amortization TuHURA Biosciences, Inc. (HURA)|Profit before payment of interest, taxes and amortization TARA (Protara Tx)|Operating profit EBITDA FATE (Fate Therapeutics, Inc.)|Aadi Bioscience, Inc. (WHWK) - Profit before interest, taxes and amortization|TCRX: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization CSBR (Champions Oncology)|xbiotech.com (XBIT) - Profit before payment of interest, taxes and amortization|CVM (CEL-SCI) - Profit before payment of interest, taxes and amortization|OSTX (OS Therapies Incorporated) - Operating profit EBITDA|Operating profit EBITDA radiopharmtheranostics.com|Operating profit EBITDA ARTV|Profit before payment of interest, taxes and amortization ANL (adlainortye.com)|Profit before payment of interest, taxes and amortization Veru Pharma VERU|Operating income before deduction of amortization Tempest Therapeutics Corp (TPST)|XLO: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization RENB (Renovaro Inc.)|muraloncology.com (MURA) - Profit before payment of interest, taxes and amortization|KAPA (Kairos Pharma) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization OKUR|GDTC (CytoMed) - Company profit before taxes, interest and amortization|Operating profit EBITDA CRIS|apollomicsinc.com - Operating profit before amortization|Tharimmune - Operating profit before deduction of amortization|Operating income before deduction of amortization Advanced Biomed Inc. (ADVB)|GNPX - Profit before payment of interest, taxes and amortization|CLDI (Calidi Biotherapeutics) - Operating profit before amortization|SBFM (Sunshine Biopharma, Inc.) - Operating profit before deduction of amortization|XBIO: Company profit before taxes, interest and amortization|SLRX (Salarius Pharmaceuticals, Inc.) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization PPBT|Profit before payment of interest, taxes and amortization American Oncology Network (AONC)|Profit before payment of interest, taxes and amortization BGNE (BeiGene Ltd)|Operating profit EBITDA CKPT (Checkpoint Therapeutics)|ELEV - Operating profit before deduction of amortization|iCAD Corp - Operating profit EBITDA|IKNA - Operating profit EBITDA|viracta.com (VIRX) - Profit before payment of interest, taxes and amortization|Operating profit before amortization MOR|NAYA (NAYA Biosciences) - Operating profit EBITDA|Operating profit before deduction of amortization ascentage.com (AAPGV)
